Evidence map›Paper›PMID 40356836›Full record

ArticleFrontiers in public health2025

Examining rural health equity and impact through the translational science benefits model: outcomes from the CTSA Consortium of Rural States (CORES).

Maggie Padek, Rebecca Butcher, Rebecca deLacerda Allen, Hilary L Surratt, Maran Subramain, Beth Tigges, Alyson G Eggleston, Jessica H Presley, Trent Matheson, Nasser Sharareh

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maggie PadekFrontiers Clinical and Translational Science Institute, University of Kansas Medical Center, Kansas City, KS, United States.
Rebecca ButcherDartmouth SYNERGY Clinical and Translational Science Institute, Geisel School of Medicine, Lebanon, NH, United States.
Rebecca deLacerda AllenCenter for Clinical and Translational Science, University of Kentucky College of Medicine, Lexington, KY, United States.
Hilary L SurrattCenter for Clinical and Translational Science, University of Kentucky College of Medicine, Lexington, KY, United States.
Maran SubramainInstitute for Clinical and Translational Science, University of Iowa, Iowa City, IA, United States.
Beth TiggesUniversity of New Mexico Health Sciences Clinical and Translational Science Center, Albuquerque, NM, United States.
Alyson G EgglestonClinical and Translational Science Institute, Pennsylvania State University, Hershey, PA, United States.
Jessica H PresleyThe Translational Research Institute, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
Trent MathesonUtah Clinical and Translational Science Institute at the University of Utah, Salt Lake City, UT, United States.
Nasser ShararehUtah Clinical and Translational Science Institute at the University of Utah, Salt Lake City, UT, United States.

Funding

RADx-UP: Improving the Response of Local Urban and Rural Communities to Disparities in Covid-19 TestingUL1TR002366 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mario Castro, JAMES STEVEN LEEDER · 2017 to 2026
$44.3M
CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
NCATS NIH HHS UL1 TR002366NCATS NIH HHS UM1 TR004409
6 · The paper itself

Abstract

Introduction: Rural communities often lack access to healthcare, have limited resources and infrastructure, and may experience suboptimal translation of evidence-based interventions into practice or measurement of translational research impact. The Consortium of Rural States (CORES), comprising eight Clinical and Translational Science Award (CTSA) hubs, is a research consortium that focuses on clinical and translational research impacting rural health. Methods: Utilizing the Translational Science Benefits Model (TSBM) framework, each CTSA hub's evaluation lead co-created an inventory of rural-focused activities, projects, and initiatives that occurred at their respective site during the funding period 2021-2023. Variables included program area; activity type and description; target population; activity status; outputs; and short-term outcomes. The evaluators then mapped site outcomes according to the four TSBM domains (clinical, community, economic, policy) and 30 subcategories (benefits). Results: 184 rural-focused activities, projects and initiatives were identified across the hubs. All rural-focused efforts involved impacts in the Community and Clinical domains of the TSBM, with >60% focusing on Community impacts. These results suggest an opportunity gap to better define Economic and Policy-level impacts in the context of rural-focused initiatives. Discussion: This work demonstrates a novel mapping of the TSBM to rural health research settings and explores the nuances of using the concepts and domains of the TSBM as a coding tool. This work gives the Consortium insight on the types of projects and impacts that are supported and how to prioritize more exploration of the full range of translational science benefits in rural health initiatives going forward.

Indexed as

Health EquityRural HealthRural PopulationTranslational Research, BiomedicalTranslational Science, BiomedicalHumansUnited StatesCTSAimpact evaluationrural healthtranslational scienceTSBM

Identifiers

PMID40356836
PMCPMC12066754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.